Age at menopause and cognitive function and decline among middle‐aged and older women in the China Health and Retirement Longitudinal Study, 2011–2018
Alzheimer's & Dementia · 2025-02 · 21 (2)
DOI: 10.1002/alz.14580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.02.2025. Verfasst von Muqi Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Menopause, Cognitive Dysfunction, Cognition, Aging. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION Chinese women experience higher dementia rates than men, yet sex‐specific risk factors are understudied. We examined how menopause age affects cognitive function and decline in aging Chinese women. METHODS Data were from 7419 postmenopausal women 45–101 years of age at baseline in the China Health and Retirement Longitudinal Study (CHARLS; 2011–2018). Menopause age was categorized using clinical cutoffs (55 years). Cognitive function was assessed with neuropsychological tests up to four times over 7 years, and associations were analyzed using multivariable‐adjusted linear mixed‐effects regression. RESULTS Compared to menopause at 50–55 years (3661/7419; 49.3%), premature (55; 366/7419; 4.9%) were associated with lower baseline cognitive scores. Although the rate of cognitive decline did not differ significantly across menopause age groups, late menopause showed a trend toward faster decline. DISCUSSION Cognitive health interventions should consider extreme menopausal age as a risk factor. Highlights Extreme menopausal ages—premature (55)—are linked to lower baseline cognition versus menopause ages 50–55, persisting over 7 years. Cognitive disadvantage for late menopause (>55) versus 50–55 tends to increase over time. Health interventions should consider extreme menopause ages in women's cognitive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Harvard Kenneth C. Griffin Graduate School of Arts and Sciences, Cambridge, Massachusetts, USA.
- Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, USA.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan, USA.
ORCID-Profile: Lindsay C Kobayashi
Förderung
- NIA NIH HHS
- NIH HHS
- Foundation for the National Institutes of Health
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Guo, M., Wu, Y., Gross, A. L., Karvonen-Gutierrez, C., & Kobayashi, L. C. (2025). Age at menopause and cognitive function and decline among middle‐aged and older women in the China Health and Retirement Longitudinal Study, 2011–2018. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14580
Vancouver
Guo M, Wu Y, Gross AL, Karvonen-Gutierrez C, Kobayashi LC. Age at menopause and cognitive function and decline among middle‐aged and older women in the China Health and Retirement Longitudinal Study, 2011–2018. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14580
BibTeX
@article{Guo2025,
author = {Guo, Muqi and Wu, Yingyan and Gross, Alden L and Karvonen-Gutierrez, Carrie and Kobayashi, Lindsay C},
title = {Age at menopause and cognitive function and decline among middle‐aged and older women in the China Health and Retirement Longitudinal Study, 2011–2018},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {2},
doi = {10.1002/alz.14580}
}
EUVIMED